Longport, Inc. EPISCAN I-200 to Be Headlined at Two Conferences; Longport, Inc. Filed End of Year Extension with the Securities
05 April 2006 - 6:05AM
Business Wire
Longport, Inc., (OTCBB: LPTI), a medical technology specialist in
high resolution ultrasound imaging, announced that it will file a
Form 12b-25 with the Securities and Exchange Commission to extend
its deadline for filing Form 10-KSB for year ended December 31,
2005. Longport, Inc. also announced that it will participate in the
planned poster presentation at the Wound Healing Society conference
to be held May 16, 2006 in Scottsdale, AZ. This poster
presentation, titled "Does the Use of High Resolution High
Frequency Ultrasound Provide a Clinical Advantage for the Detection
and Prevention of Pressure Ulcers?" is the result of a study done
by Director of Clinical Support at Longport, Inc., Connie
Phillips-Jones RN, MSN. The presentation will highlight findings
that Longport, Inc.'s EPISCAN may be more accurate than overt
clinical signs when predicting risk of pressure ulcer development.
In addition, Longport, Inc. plans to exhibit at the Symposium for
Advanced Wound Care (SAWC) from April 29-May 3, 2006 in San
Antonio, TX. This exhibit provides exposure to the American Academy
of Wound Care (AAWC), and to meet with AAWC members for research
and development strategies for greater access to the wound care
market. About Longport, Inc. Longport, Inc. of Glen Mills,
Pennsylvania, is a medical technology company that specializes in
high resolution ultrasound imaging. After several years and a
multi-million dollar investment in the technology, Longport has
secured patents, copyrights, and FDA permission to market. The
Company's technology has been used to engineer a unique high
resolution ultrasound imaging system. For further information
please contact Longport, Inc. at 1-800-289-6863 or visit our
website at www.longportinc.com. Forward-looking Information and the
Private Securities Litigation Reform Act of 1995 Certain statements
in this press release, including statements concerning product
development milestones and anticipated events, are "forward-looking
statements" within the Private Litigation Reform Act of 1995.
Forward Looking Statements are based on the opinions and estimates
of management at the time the statements are made and are subject
to certain risks and uncertainties that could cause actual results
to differ materially from those anticipated in the forward-looking
statements. The words "believe," "expect," "intend," "anticipate,"
variations of such words, and similar expressions identify
forward-looking statements, but their absence does not mean that
the statement is not forward-looking. These statements are not
guarantees of future performance and are subject to certain risks,
uncertainties and assumptions that are difficult to predict.
Factors that could affect Longport's actual results include, among
others, uncertainties as to the Company's ability to manage
potential problems, delays or anticipated expenses, including
problems, delays or expenses involving manufacturing. Readers are
cautioned not to place undue reliance upon these forward-looking
statements that speak only to the date of this release. Reference
is made to Longport's 2004 annual report on Form 10-K filed with
the Securities and Exchange Commission for a more definitive
description of such factors. Longport, Inc. undertakes no
obligation to update publicly any forward-looking statements to
reflect new information, events or circumstances after the date of
this release or to reflect the occurrence of unanticipated events.
Longport (CE) (USOTC:LPTI)
Historical Stock Chart
From Nov 2024 to Dec 2024
Longport (CE) (USOTC:LPTI)
Historical Stock Chart
From Dec 2023 to Dec 2024
Real-Time news about Longport Inc (CE) (OTCMarkets): 0 recent articles
More Longport, Inc. News Articles